Diabetes drug linked to increased risk of heart failure
Thursday, August 20, 2009 - 10:42
in Health & Medicine
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on BMJ.com today.